Introduction
Chitosan, a partially deacetylated polymer of N-acetyl
glucosamine derived from the polysaccharide chitin, appears
to bind to negatively charged lipids in animal trials, hence
reducing their gastrointestinal uptake1–3 and lowering serum
cholesterol.4,5 Some human trials have suggested that chitosan
may decrease body weight and serum lipids,6